Skip to Content
Print Share

Medications for Joint Infection

About Joint Infection:  Invasion of a joint with organisms that have the potential to cause disease.

Drugs Used to Treat Joint Infection

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
clindamycin B N Add review Rate

Generic name: clindamycin systemic

Brand names:  Cleocin, Cleocin Phosphate, Cleocin HCl, Cleocin Pediatric …show all

Drug class: lincomycin derivatives

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Cipro C N Add review
10

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

ciprofloxacin C N Add review
6.0

Generic name: ciprofloxacin systemic

Brand names:  Cipro, Cipro I.V., Cipro XR

Drug class: quinolones

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

metronidazole B N X Add review Rate

Generic name: metronidazole systemic

Brand names:  Flagyl, Flagyl IV, Flagyl 375

Drug class: amebicides, miscellaneous antibiotics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

cefuroxime B N Add review Rate

Generic name: cefuroxime systemic

Brand names:  Ceftin, Zinacef

Drug class: second generation cephalosporins

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

ceftriaxone B N 1 review
2.0

Generic name: ceftriaxone systemic

Drug class: third generation cephalosporins

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Flagyl B N X Add review Rate

Generic name: metronidazole systemic

Drug class: amebicides, miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Cleocin B N Add review Rate

Generic name: clindamycin systemic

Drug class: lincomycin derivatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Ancef B N Add review Rate

Generic name: cefazolin systemic

Drug class: first generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

cefazolin B N Add review Rate

Generic name: cefazolin systemic

Brand names:  Ancef, Kefzol

Drug class: first generation cephalosporins

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

ceftazidime B N Add review Rate

Generic name: ceftazidime systemic

Brand names:  Fortaz, Tazicef, Ceptaz

Drug class: third generation cephalosporins

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Unasyn B N Add review Rate

Generic name: ampicillin / sulbactam systemic

Drug class: beta-lactamase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

amikacin D N Add review Rate

Generic name: amikacin systemic

Brand names:  Amikin, Amikin Pediatric

Drug class: aminoglycosides

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Ceftin B N Add review Rate

Generic name: cefuroxime systemic

Drug class: second generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Amikin D N Add review Rate

Generic name: amikacin systemic

Drug class: aminoglycosides

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Zosyn B N Add review Rate

Generic name: piperacillin / tazobactam systemic

Drug class: beta-lactamase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Cipro I.V. C N Add review Rate

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

Cipro XR C N Add review Rate

Generic name: ciprofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Cleocin Phosphate B N Add review Rate

Generic name: clindamycin systemic

Drug class: lincomycin derivatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Flagyl IV B N X Add review Rate

Generic name: metronidazole systemic

Drug class: amebicides, miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Cleocin HCl B N Add review Rate

Generic name: clindamycin systemic

Drug class: lincomycin derivatives

For consumers: dosage, interactions, side effects

Cleocin Pediatric B N Add review Rate

Generic name: clindamycin systemic

Drug class: lincomycin derivatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Flagyl 375 B N X Add review Rate

Generic name: metronidazole systemic

Drug class: amebicides, miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Floxin C N Add review Rate

Generic name: ofloxacin systemic

Drug class: quinolones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Mefoxin B N Add review Rate

Generic name: cefoxitin systemic

Drug class: second generation cephalosporins

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Page 1 2 Next

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drugs.com Mobile Apps

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Explore Apps
Hide